817 related articles for article (PubMed ID: 30864227)
1. Inhibition of high mobility group box 1 (HMGB1) attenuates podocyte apoptosis and epithelial-mesenchymal transition by regulating autophagy flux.
Jin J; Gong J; Zhao L; Zhang H; He Q; Jiang X
J Diabetes; 2019 Oct; 11(10):826-836. PubMed ID: 30864227
[TBL] [Abstract][Full Text] [Related]
2. Paecilomyces cicadae-fermented Radix astragali activates podocyte autophagy by attenuating PI3K/AKT/mTOR pathways to protect against diabetic nephropathy in mice.
Yang F; Qu Q; Zhao C; Liu X; Yang P; Li Z; Han L; Shi X
Biomed Pharmacother; 2020 Sep; 129():110479. PubMed ID: 32768963
[TBL] [Abstract][Full Text] [Related]
3. Exosome secreted from adipose-derived stem cells attenuates diabetic nephropathy by promoting autophagy flux and inhibiting apoptosis in podocyte.
Jin J; Shi Y; Gong J; Zhao L; Li Y; He Q; Huang H
Stem Cell Res Ther; 2019 Mar; 10(1):95. PubMed ID: 30876481
[TBL] [Abstract][Full Text] [Related]
4. Tripterygium glycoside suppresses epithelial‑to‑mesenchymal transition of diabetic kidney disease podocytes by targeting autophagy through the mTOR/Twist1 pathway.
Tao M; Zheng D; Liang X; Wu D; Hu K; Jin J; He Q
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165172
[TBL] [Abstract][Full Text] [Related]
5. Advanced glycation end-products suppress autophagic flux in podocytes by activating mammalian target of rapamycin and inhibiting nuclear translocation of transcription factor EB.
Zhao X; Chen Y; Tan X; Zhang L; Zhang H; Li Z; Liu S; Li R; Lin T; Liao R; Zhang Q; Dong W; Shi W; Liang X
J Pathol; 2018 Jun; 245(2):235-248. PubMed ID: 29570219
[TBL] [Abstract][Full Text] [Related]
6. Curcumin alleviates diabetic nephropathy via inhibiting podocyte mesenchymal transdifferentiation and inducing autophagy in rats and MPC5 cells.
Tu Q; Li Y; Jin J; Jiang X; Ren Y; He Q
Pharm Biol; 2019 Dec; 57(1):778-786. PubMed ID: 31741405
[No Abstract] [Full Text] [Related]
7. Research Progress on Mechanism of Podocyte Depletion in Diabetic Nephropathy.
Dai H; Liu Q; Liu B
J Diabetes Res; 2017; 2017():2615286. PubMed ID: 28791309
[TBL] [Abstract][Full Text] [Related]
8. Jixuepaidu Tang-1 inhibits epithelial-mesenchymal transition and alleviates renal damage in DN mice through suppressing long non-coding RNA LOC498759.
Jin J; Zhang Z; Chen J; Liu Y; Chen Q; Wang Q
Cell Cycle; 2019 Nov; 18(22):3125-3136. PubMed ID: 31564202
[TBL] [Abstract][Full Text] [Related]
9. p66Shc regulates podocyte autophagy in high glucose environment through the Notch-PTEN-PI3K/Akt/mTOR pathway.
Zheng D; Tao M; Liang X; Li Y; Jin J; He Q
Histol Histopathol; 2020 Apr; 35(4):405-415. PubMed ID: 31650524
[TBL] [Abstract][Full Text] [Related]
10. The protective effects of rapamycin on cell autophagy in the renal tissues of rats with diabetic nephropathy via mTOR-S6K1-LC3II signaling pathway.
Liu L; Yang L; Chang B; Zhang J; Guo Y; Yang X
Ren Fail; 2018 Nov; 40(1):492-497. PubMed ID: 30200803
[TBL] [Abstract][Full Text] [Related]
11. LncRNA Hoxb3os protects podocytes from high glucose-induced cell injury through autophagy dependent on the Akt-mTOR signaling pathway.
Jin J; Gong J; Zhao L; Li Y; He Q
Acta Biochim Pol; 2021 Oct; 68(4):619-625. PubMed ID: 34648253
[TBL] [Abstract][Full Text] [Related]
12. Spironolactone promotes autophagy via inhibiting PI3K/AKT/mTOR signalling pathway and reduce adhesive capacity damage in podocytes under mechanical stress.
Li D; Lu Z; Xu Z; Ji J; Zheng Z; Lin S; Yan T
Biosci Rep; 2016 Aug; 36(4):. PubMed ID: 27129295
[TBL] [Abstract][Full Text] [Related]
13. TXNIP deficiency mitigates podocyte apoptosis via restraining the activation of mTOR or p38 MAPK signaling in diabetic nephropathy.
Song S; Qiu D; Wang Y; Wei J; Wu H; Wu M; Wang S; Zhou X; Shi Y; Duan H
Exp Cell Res; 2020 Mar; 388(2):111862. PubMed ID: 31982382
[TBL] [Abstract][Full Text] [Related]
14. SPAG5-AS1 inhibited autophagy and aggravated apoptosis of podocytes via SPAG5/AKT/mTOR pathway.
Xu J; Deng Y; Wang Y; Sun X; Chen S; Fu G
Cell Prolif; 2020 Feb; 53(2):e12738. PubMed ID: 31957155
[TBL] [Abstract][Full Text] [Related]
15. LncRNA AA465934 Improves Podocyte Injury by Promoting Tristetraprolin-Mediated HMGB1 DownRegulation in Diabetic Nephropathy.
Yang N; Zhang Y; Ren P; Zhao L; Zheng D; Fu L; Jin J
Mol Cell Biol; 2024; 44(3):87-102. PubMed ID: 38520226
[TBL] [Abstract][Full Text] [Related]
16. Apelin involved in progression of diabetic nephropathy by inhibiting autophagy in podocytes.
Liu Y; Zhang J; Wang Y; Zeng X
Cell Death Dis; 2017 Aug; 8(8):e3006. PubMed ID: 28837139
[TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
Xing L; Fang J; Zhu B; Wang L; Chen J; Wang Y; Huang J; Wang H; Yao X
Life Sci; 2021 Mar; 269():119068. PubMed ID: 33476631
[TBL] [Abstract][Full Text] [Related]
18. Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli.
Wang X; Gao L; Lin H; Song J; Wang J; Yin Y; Zhao J; Xu X; Li Z; Li L
Eur J Pharmacol; 2018 Apr; 824():170-178. PubMed ID: 29444469
[TBL] [Abstract][Full Text] [Related]
19. [Down-regulation of PHLPP1 expression ameliorates high glucose-induced autophagy inhibition and apoptosis promotion of podocytes by activating PI3K/AKT/mTOR pathway].
Cai G; Zhang J; Wang R
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Jan; 37(1):8-15. PubMed ID: 33441223
[TBL] [Abstract][Full Text] [Related]
20. Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition.
Dai HY; Ma LN; Cao Y; Chen XL; Shi H; Fan YP; Yang B
J Cell Biochem; 2017 Nov; 118(11):3706-3712. PubMed ID: 28370212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
